molecule_chembl_id,target_chembl_id,target_pref_name,standard_type,standard_relation,standard_value,standard_units,assay_chembl_id,assay_type,assay_description,document_chembl_id,readout,smiles,pActivity
CHEMBL37853,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,3700.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,5.431798275933005
CHEMBL290969,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2500.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,5.6020599913279625
CHEMBL36817,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4900.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,CCCCC[C@H](O)CC[C@@H]1[C@@H](CCCCCCC(=O)O)[C@@H](O)C[C@H]1O,5.309803919971486
CHEMBL369797,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1300.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CCC(O)CSc2cccs2)[C@H](O)C[C@@H]1O,5.886056647693163
CHEMBL173680,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2400.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CCC(O)CSc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,5.619788758288394
CHEMBL36041,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6700.0,nM,CHEMBL763183,B,Affinity for Prostanoid EP2 receptor expressed in CHO cells,CHEMBL1132967,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](CC[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O,5.173925197299173
CHEMBL400404,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,32000.0,nM,CHEMBL896002,B,Inhibition of human recombinant EP2 receptor expressed in 293EBNA cells,CHEMBL1148848,IC50,CC(=O)Nc1cccc(-c2ccc(Cc3ocnc3C(=O)N[C@@H](Cc3ccccc3)C(=O)O)cc2)c1,4.494850021680094
CHEMBL521609,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,12500.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc4ccccc4c3)cccc21,4.903089986991944
CHEMBL489310,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4200.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc(Cl)c(Cl)c3)cccc21,5.376750709602099
CHEMBL459885,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,9600.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc(Cl)cc3Cl)cccc21,5.017728766960431
CHEMBL475348,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,7680.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)c(Cl)c3)cccc21,5.114638779968488
CHEMBL475349,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,9300.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)cc3Cl)cccc21,5.031517051446064
CHEMBL521777,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,10000.0,nM,CHEMBL960018,B,Displacement of radioligand from EP2 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)c(F)c3)cccc21,5.0
CHEMBL479664,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2300.0,nM,CHEMBL1023728,B,Binding affinity to human EP2 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3ccc(F)c(F)c3)=C1N(Cc1ccc(F)c(F)c1)C(=O)C2,5.638272163982407
CHEMBL479263,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,13900.0,nM,CHEMBL1023728,B,Binding affinity to human EP2 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3cc(F)c(F)cc3F)=C1N(Cc1ccc(F)c(F)c1)C(=O)C2,4.856985199745905
CHEMBL467114,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1584.89,nM,CHEMBL1009657,B,Inhibition of EP2 receptor,CHEMBL1138602,IC50,O=C([O-])c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1.[Na+],5.800000874803203
CHEMBL565591,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4169.0,nM,CHEMBL1045307,B,Displacement of [3H]PGE2 from human EP2 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,Cc1cn(Cc2ccc(Cl)cc2Cl)c2c(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,5.3799681048737025
CHEMBL565992,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4832.0,nM,CHEMBL1045307,B,Displacement of [3H]PGE2 from human EP2 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(COc1cccc2ncn(Cc3ccc(Cl)cc3Cl)c12)NS(=O)(=O)c1cc(Cl)c(Cl)s1,5.315873074386925
CHEMBL467632,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,12261.0,nM,CHEMBL1045307,B,Displacement of [3H]PGE2 from human EP2 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(COc1cccc2[nH]cc(Cc3ccc4ccccc4c3)c12)NS(=O)(=O)c1cc(Cl)c(Cl)s1,4.911474107568744
CHEMBL565799,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,32921.0,nM,CHEMBL1045307,B,Displacement of [3H]PGE2 from human EP2 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,Cc1cn(Cc2ccc3ccccc3c2)c2c(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,4.482526981239664
CHEMBL1081186,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,19800.0,nM,CHEMBL1101722,B,Binding affinity to human EP2 receptor by radioligand displacement assay,CHEMBL1154363,IC50,Cc1cn(Cc2ccc(Cl)cc2Cl)c2c(-c3cc(NS(=O)(=O)c4ccc(F)c(F)c4)no3)cc(F)cc12,4.703334809738469
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,37.7,nM,CHEMBL1120701,B,Binding affinity to EP2 receptor,CHEMBL1155461,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,7.423658649794207
CHEMBL2385903,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,9500.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,O=C(O)Cn1c2c(c3cc(F)ccc31)CN(C(=O)CCc1cccc3ccccc13)CC2,5.022276394711152
CHEMBL2386080,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,7400.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,O=C(O)Cn1c2c(c3cc(Cl)ccc31)CN(C(=O)c1cccc3ccccc13)CC2,5.130768280269024
CHEMBL2386079,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6600.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,O=C(O)Cn1c2c(c3ccccc31)CN(C(=O)c1cccc3ccccc13)CC2,5.180456064458131
CHEMBL2385904,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6400.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,CCc1ccc(-c2ccc(C(=O)N3CCc4c(c5ccccc5n4CC(=O)O)C3)cc2)cc1,5.1938200260161125
CHEMBL2385900,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2700.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,O=C(O)Cn1c2c(c3cc(F)cc(Cl)c31)CN(C(=O)c1cccc3ccccc13)CC2,5.568636235841012
CHEMBL2386081,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2600.0,nM,CHEMBL2388930,B,Inhibition of beta-arrestin binding to recombinant human prostanoid EP2 receptor expressed in HEK293 cell membranes by beta-lactamase complementation assay,CHEMBL2385063,IC50,O=C(O)Cn1c2c(c3cc(F)ccc31)CN(C(=O)c1cccc3ccccc13)CC2,5.585026652029182
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2.2,nM,CHEMBL2394990,B,Binding affinity to human EP2 receptor (unknown origin) by radioligand displacement assay,CHEMBL2390917,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.657577319177793
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,3.3,nM,CHEMBL2394934,B,Binding affinity to human prostanoid EP2 receptor by radioligand displacement assay,CHEMBL2390830,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.481486060122112
CHEMBL3586362,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,C[C@@H]1COc2c(Cl)cc(-n3ccc4cc(F)ccc43)cc2CN1Cc1cc[nH]c(=O)c1,8.698970004336019
CHEMBL3586361,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,8.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,C[C@@H]1COc2c(Cl)cc(-c3csc4ccccc34)cc2CN1Cc1cc[nH]c(=O)c1,8.096910013008056
CHEMBL3586360,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,8.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,O=c1cc(CN2CCOc3c(Cl)cc(-n4ccc5cc(F)ccc54)cc3C2)cc[nH]1,8.096910013008056
CHEMBL3586359,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,20.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,O=c1cc(CN2CCOc3c(Cl)cc(-c4csc5ccccc45)cc3C2)cc[nH]1,7.698970004336019
CHEMBL3586357,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,13000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCC(=O)N(Cc1cccnc1)C2,4.886056647693163
CHEMBL3586356,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,CN1CCN(Cc2cccnc2)Cc2cc(-c3csc4ccccc34)ccc21,5.3979400086720375
CHEMBL3586355,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,c1cncc(CN2CCNc3ccc(-c4csc5ccccc45)cc3C2)c1,5.221848749616356
CHEMBL3586354,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1600.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,c1cncc(CN2CCCc3ccc(-c4csc5ccccc45)cc3C2)c1,5.795880017344075
CHEMBL3586353,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,80.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,Clc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,7.096910013008056
CHEMBL3586352,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,200.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,Cc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,6.698970004336019
CHEMBL3586350,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,14000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,CCOc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,4.853871964321762
CHEMBL3586349,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1500.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,Oc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,5.823908740944319
CHEMBL3586348,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,c1cncc(CN2CCOc3ccc(-c4csc5ccccc45)cc3C2)c1,5.958607314841775
CHEMBL3586347,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,30.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(N2CCc3cc(Cl)ccc32)cc2c1OCCN(Cc1cccnc1)C2,7.522878745280337
CHEMBL3586346,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,90.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3cc(F)ccc32)cc2c1OCCN(Cc1cccnc1)C2,7.045757490560675
CHEMBL3586345,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3cc(C#N)ccc32)cc2c1OCCN(Cc1cccnc1)C2,7.0
CHEMBL3586344,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,5600.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3cccc(Cl)c32)cc2c1OCCN(Cc1cccnc1)C2,5.251811972993799
CHEMBL3586343,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,800.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3ccc(Cl)cc32)cc2c1OCCN(Cc1cccnc1)C2,6.096910013008056
CHEMBL3586342,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,80.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3cc(Cl)ccc32)cc2c1OCCN(Cc1cccnc1)C2,7.096910013008056
CHEMBL3586341,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,400.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3c(Cl)cccc32)cc2c1OCCN(Cc1cccnc1)C2,6.3979400086720375
CHEMBL3586340,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,60.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2cc(Cl)c3ccccc32)cc2c1OCCN(Cc1cccnc1)C2,7.221848749616356
CHEMBL3586339,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2cn(C)c3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,5.958607314841775
CHEMBL3586338,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2700.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2c[nH]c3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,5.568636235841012
CHEMBL3586337,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,300.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2ccc3ccccc32)cc2c1OCCN(Cc1cccnc1)C2,6.522878745280337
CHEMBL3586336,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6400.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-n2cnc3ccccc32)cc2c1OCCN(Cc1cccnc1)C2,5.1938200260161125
CHEMBL3586335,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,400.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2nsc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,6.3979400086720375
CHEMBL3586334,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,10000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2ccc(Cl)cc2)cc2c1OCCN(Cc1cccnc1)C2,5.0
CHEMBL3586333,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,700.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2cccc(Cl)c2)cc2c1OCCN(Cc1cccnc1)C2,6.154901959985743
CHEMBL3586332,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,12000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2ccccc2Cl)cc2c1OCCN(Cc1cccnc1)C2,4.920818753952375
CHEMBL3586330,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,15000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2cccc(C)c2)cc2c1OCCN(Cc1cccnc1)C2,4.823908740944319
CHEMBL3586328,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,300.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2cccc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,6.522878745280337
CHEMBL3586327,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,15000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2ccccc2)cc2c1OCCN(Cc1cccnc1)C2,4.823908740944319
CHEMBL3586326,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2800.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2cc3ccccc3s2)cc2c1OCCN(Cc1cccnc1)C2,5.552841968657781
CHEMBL3586324,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccc(C#N)c1)C2,7.0
CHEMBL3586323,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,30000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccc(Cl)c1)C2,4.522878745280337
CHEMBL3586322,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccc(S(C)(=O)=O)cc1)C2,7.0
CHEMBL3586321,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,600.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccc(C#N)cc1)C2,6.221848749616356
CHEMBL3586320,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,600.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COC(=O)c1ccc(CN2CCOc3c(cc(-c4csc5ccccc45)cc3OC)C2)cc1,6.221848749616356
CHEMBL3586319,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1800.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1ccc(CN2CCOc3c(cc(-c4csc5ccccc45)cc3OC)C2)cc1,5.7447274948966935
CHEMBL3586318,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,30000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccc(C)cc1)C2,4.522878745280337
CHEMBL3586317,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,30000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccc(Cl)cc1)C2,4.522878745280337
CHEMBL3586316,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,10000.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccccc1)C2,5.0
CHEMBL3586315,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,200.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccc(=O)[nH]c1)C2,6.698970004336019
CHEMBL3586314,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,100.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1ccc(CN2CCOc3c(cc(-c4csc5ccccc45)cc3OC)C2)cn1,7.0
CHEMBL3586313,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,200.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1OC)C2,6.698970004336019
CHEMBL3586312,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,20.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cncnc1)C2,7.698970004336019
CHEMBL3586311,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,200.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccncc1)C2,6.698970004336019
CHEMBL3586310,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,700.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1ccccn1)C2,6.154901959985743
CHEMBL3586309,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,70.0,nM,CHEMBL3588430,B,Displacement of [3H]-PGE2 from human EP2 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,7.154901959985743
CHEMBL3115074,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1630.0,nM,CHEMBL3603414,B,Displacement of [3H]-PGE2 from human EP2 receptor by liquid scintillation counting analysis,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,5.787812395596042
CHEMBL3740325,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,3700.0,nM,CHEMBL3744264,B,Antagonist activity at human EP2 receptor,CHEMBL3739413,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(Cl)c2)cc2ccccc12,5.431798275933005
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2.6,nM,CHEMBL3779739,B,Displacement of [3H]PGE2 from human recombinant prostanoid EP2 receptor expressed in HEK293 cells,CHEMBL3774372,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.585026652029182
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2.6,nM,CHEMBL3876385,B,Displacement of [3H]PGE2 from human recombinant EP2 receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method,CHEMBL3875185,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.585026652029182
CHEMBL3956391,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,2281.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,O=C(O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1c1ccc2c(c1)CCC2O,5.641874714723351
CHEMBL3986829,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,5200.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CCCC1(C(O)c2cccc([C@@H]3[C@@H](Cc4cccc(OCC(=O)O)c4)[C@H](Cl)C[C@H]3O)c2)CCC1,5.2839966563652006
CHEMBL3983069,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,3630.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CC(C)(C)C(O)c1ccc([C@@H]2[C@@H](CCCCCCC(=O)O)[C@H](Cl)C[C@H]2O)cc1,5.440093374963888
CHEMBL3920560,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1537.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CC(C)(C)C(O)c1ccc([C@@H]2[C@@H](C/C=C\CCCC(=O)O)[C@H](Cl)C[C@H]2O)cc1,5.813326132500254
CHEMBL3934202,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,13150.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,O=C(O)CCC/C=C\C[C@@H]1[C@@H](c2ccc(CO)cc2)[C@H](O)C[C@H]1Cl,4.881074247174223
CHEMBL3922121,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,8950.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CC(C)(CO)c1ccc([C@@H]2[C@@H](CCCCCCC(=O)O)[C@H](Cl)C[C@H]2O)cc1,5.048176964684088
CHEMBL3919393,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,18735.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CC(C)(CO)c1ccc([C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)cc1,4.727346302570183
CHEMBL3971493,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,48765.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,COC(=O)CCC/C=C\C[C@@H]1[C@@H](c2ccc(C(C)(C)CO)cc2)[C@H](O)C[C@H]1Cl,4.311891771448192
CHEMBL3976116,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,6251.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl,5.204050501097196
CHEMBL3909111,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,13139.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3O)[C@H](O)C[C@H]1Cl,4.8814376873643965
CHEMBL3973312,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4185.0,nM,CHEMBL3883093,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins,CHEMBL3882734,IC50,CC(C)(CO)c1ccc([C@@H]2[C@@H](C/C=C\CCCC(=O)O)[C@H](Cl)C[C@H]2O)cc1,5.378304537670721
CHEMBL3895324,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1500.0,nM,CHEMBL3887097,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C(=O)C(C)(C)[C@H]1O,5.823908740944319
CHEMBL4092846,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,236.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(F)ccc2Oc2ccc(F)cc2)cc1,6.627087997029893
CHEMBL4065183,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1290.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(Cl)cnc2Oc2ccc(F)cc2)cc1,5.889410289700751
CHEMBL4096216,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4360.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,5.360513510731414
CHEMBL591666,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,709.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,6.149353764816933
CHEMBL4099851,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1890.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(F)c1)c1ccc(C(=O)O)cc1,5.723538195826755
CHEMBL4094572,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,3320.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(C#N)c1)c1ccc(C(=O)O)cc1,5.478861916295964
CHEMBL4078648,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1620.0,nM,CHEMBL3997116,B,Antagonist activity at human EP2 receptor,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1cccc(F)c1)c1ccc(C(=O)O)cc1,5.790484985457369
CHEMBL3707245,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,10.0,nM,CHEMBL4326150,B,Displacement of [3H]prostaglandin E2 from human EP2 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting,CHEMBL4325826,IC50,O=C(O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)n1,8.0
CHEMBL4297666,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4180.0,nM,CHEMBL4326150,B,Displacement of [3H]prostaglandin E2 from human EP2 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting,CHEMBL4325826,IC50,CC(C)OC(=O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)n1,5.3788237182249645
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4.0,nM,CHEMBL4326150,B,Displacement of [3H]prostaglandin E2 from human EP2 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting,CHEMBL4325826,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.397940008672037
CHEMBL4790821,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,4400.0,nM,CHEMBL4671518,B,Displacement of [3H]prostaglandin E2 from full-length recombinant human EP2 receptor expressed in HEK293 cell membranes measured after 120 mins by scintillation counting method,CHEMBL4665834,IC50,Cc1c(-c2cccs2)nc2ccc(Br)cc2c1C(=O)NCCc1cccnc1,5.356547323513812
CHEMBL3286797,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,5.0,nM,CHEMBL4886922,B,Inhibition of binding to PTGER2,CHEMBL4507298,IC50,COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1,8.301029995663981
CHEMBL4552554,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1300.0,nM,CHEMBL4886922,B,Inhibition of binding to PTGER2,CHEMBL4507298,IC50,O=C(c1ccc(F)cc1)N1CC(COc2ccc(Br)cc2)(C(=O)O)C1,5.886056647693163
CHEMBL4552554,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,1300.0,nM,CHEMBL5210562,B,Affinity Biochemical interaction (Enzymatic inhibition assay) EUB0000342a PTGER2,CHEMBL5210307,IC50,O=C(c1ccc(F)cc1)N1CC(COc2ccc(Br)cc2)(C(=O)O)C1,5.886056647693163
CHEMBL3286797,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,5.0,nM,CHEMBL5210567,B,Affinity Biochemical interaction (Enzymatic inhibition assay) EUB0000351a PTGER2,CHEMBL5210307,IC50,COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1,8.301029995663981
CHEMBL3670685,CHEMBL1881,Prostanoid EP2 receptor,IC50,=,928.2,nM,CHEMBL5321025,B,Antagonist activity at EP2 receptor (unknown origin),CHEMBL5316375,IC50,C[C@H](NC(=O)c1c(C(F)F)nn(C)c1Oc1cccc(C(F)(F)F)c1)c1ccc(C(=O)O)cc1,6.032358435916988
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.1,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.67778070526608
CHEMBL271896,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,33.0,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,CCCC1([C@H](O)C/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)OC)CCC1,7.481486060122112
CHEMBL1628262,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,32.0,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,CCCC1([C@@H](O)C/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)CCC1,7.494850021680094
CHEMBL64246,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,3.8,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,CCC1([C@@H](O)C/C=C/[C@@H]2[C@@H](C/C=C\CCCC(=O)O)[C@H](Cl)C[C@H]2O)CCC1,8.42021640338319
CHEMBL3286796,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1.8,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,C=CCC1([C@@H](O)C/C=C/[C@@H]2[C@@H](C/C=C\CCCC(=O)O)[C@H](Cl)C[C@H]2O)CCC1,8.744727494896694
CHEMBL563646,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,5.0,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,CC(C)(C)c1ccc(CN(Cc2cccc(OCC(=O)O)c2)S(=O)(=O)c2cccnc2)cc1,8.301029995663981
CHEMBL2107783,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.8,nM,CHEMBL3294249,B,Agonist activity at EP2 receptor (unknown origin) by functional assay,CHEMBL3286161,EC50,O=C(O)COc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)c1,8.55284196865778
CHEMBL3754586,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,0.39,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1CCC(=O)N1CCSc1nc(C(=O)O)cs1,9.4089353929735
CHEMBL3752377,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,0.91,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CCCCC(C)(C)[C@H](O)/C=C/[C@H]1CCC(=O)N1CCSc1nc(C(=O)O)cs1,9.040958607678906
CHEMBL3753853,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,7.4,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CCCCC(C)(C)[C@H](O)/C=C/[C@H]1COC(=O)N1CCSc1nc(C(=O)O)cs1,8.130768280269024
CHEMBL3752406,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,5.7,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CC(C)(CCCCF)[C@H](O)/C=C/[C@H]1COC(=O)N1CCSc1nc(C(=O)O)cs1,8.244125144327509
CHEMBL3753221,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.9,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CCCCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,8.537602002101044
CHEMBL3751951,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.9,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,O=C(O)c1csc(SCCN2C(=O)OC[C@@H]2/C=C/[C@@H](O)C2(CCCCF)CCC2)n1,8.537602002101044
CHEMBL3753788,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,18.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,COCCCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,7.7447274948966935
CHEMBL3753898,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,29.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CCOCCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,7.537602002101044
CHEMBL3753622,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,160.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,O=C(O)c1csc(SCCN2C(=O)OC[C@@H]2/C=C/[C@@H](O)C2(CCc3ccccc3)CCC2)n1,6.795880017344075
CHEMBL3754197,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,60.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,O=C(O)c1csc(SCCN2C(=O)OC[C@@H]2/C=C/[C@@H](O)C2(CCC3CCCCC3)CCC2)n1,7.221848749616356
CHEMBL3753268,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,21.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CC#CCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,7.6777807052660805
CHEMBL3752435,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,3700.0,nM,CHEMBL3757317,B,Agonist activity at human EP2 receptor,CHEMBL3751723,EC50,CC(C)(C)CCC1([C@H](O)/C=C/[C@H]2COC(=O)N2CCSc2nc(C(=O)O)cs2)CCC1,5.431798275933005
CHEMBL3793045,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,9.0,nM,CHEMBL3794974,B,Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay,CHEMBL3792278,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4cccc(C(F)(F)F)c4)[C@H](O)C[C@@H]3O2)n1,8.045757490560675
CHEMBL3794016,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.3,nM,CHEMBL3794974,B,Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay,CHEMBL3792278,EC50,Cc1cc(OC[C@@H]2[C@H]3CC[C@H](c4nc(C(=O)O)cs4)O[C@H]3C[C@H]2O)cc(C)c1Cl,8.638272163982407
CHEMBL3793862,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,3.7,nM,CHEMBL3794974,B,Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay,CHEMBL3792278,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4cc(Cl)c(Cl)cc4Cl)[C@H](O)C[C@@H]3O2)n1,8.431798275933005
CHEMBL3792632,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,2.3,nM,CHEMBL3794974,B,Agonist activity at human EP2 receptor expressed in HEK293 cells after 24 hrs beta-arrestin recruitment assay,CHEMBL3792278,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4ccc(Cl)c(Cl)c4Cl)[C@H](O)C[C@@H]3O2)n1,8.638272163982407
CHEMBL548,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,346.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,6.460923901207224
CHEMBL3805767,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,203.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4ccccc4Cl)[C@H](O)C[C@@H]3O2)n1,6.692503962086787
CHEMBL3806284,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,11.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4ccccc4C(F)(F)F)[C@H](O)C[C@@H]3O2)n1,7.958607314841775
CHEMBL3805981,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,69.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4cccc(OC(F)(F)F)c4)[C@H](O)C[C@@H]3O2)n1,7.161150909262744
CHEMBL3793045,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,9.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4cccc(C(F)(F)F)c4)[C@H](O)C[C@@H]3O2)n1,8.045757490560675
CHEMBL3805122,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,4500.0,nM,CHEMBL3808246,B,Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay,CHEMBL3804774,EC50,O=C(O)c1csc([C@H]2CC[C@@H]3[C@@H](COc4ccc(OC(F)(F)F)cc4)[C@H](O)C[C@@H]3O2)n1,5.346787486224656
CHEMBL3891401,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,28.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CC(C)(C)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)o2)cc1,7.552841968657781
CHEMBL3908484,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,51.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CC(C)(C)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,7.292429823902063
CHEMBL3929446,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,548.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CC(C)(C)c1ccc(N2C(=O)CC[C@@H]2CCCCCCC(=O)O)cc1,6.261219441515631
CHEMBL3928130,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,26.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)o2)cc1,7.585026652029182
CHEMBL3905811,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1218.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CC(C)C(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)o2)cc1,5.914352711703144
CHEMBL3906402,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,148.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,O=C(O)c1ccc(COC[C@H]2CCC(=O)N2c2ccc(C(O)Cc3ccccc3)cc2)o1,6.8297382846050425
CHEMBL3892847,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1.5,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,8.823908740944319
CHEMBL3924987,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,517.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2cccc(C(=O)O)c2)cc1,6.286509456906058
CHEMBL3975238,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,8.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,8.096910013008056
CHEMBL3977724,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1.5,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,8.823908740944319
CHEMBL3907809,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,27.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,7.568636235841012
CHEMBL3918349,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,312.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCC(O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,6.505845405981557
CHEMBL3962183,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,15.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2C=CCc2ccc(C(=O)O)s2)cc1,7.823908740944319
CHEMBL3971632,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,0.15,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2CCCc2ccc(C(=O)O)s2)cc1,9.823908740944319
CHEMBL3920756,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1.6,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(=O)c1ccc(N2C(=O)CC[C@@H]2CCCc2ccc(C(=O)O)s2)cc1,8.795880017344075
CHEMBL3921784,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,8.0,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCC(=O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,8.096910013008056
CHEMBL3947001,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,0.6,nM,CHEMBL3881176,B,Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation,CHEMBL3880426,EC50,CCCCCCC(O)c1ccc(N2C(=O)CC[C@@H]2CCCc2ccc(C(=O)O)s2)cc1,9.221848749616356
CHEMBL3891401,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,189.0,nM,CHEMBL3883104,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 6.0 membranes incubated for 60 mins,CHEMBL3882734,EC50,CC(C)(C)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)o2)cc1,6.723538195826755
CHEMBL3908484,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,27.0,nM,CHEMBL3883104,B,Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 6.0 membranes incubated for 60 mins,CHEMBL3882734,EC50,CC(C)(C)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)O)s2)cc1,7.568636235841012
CHEMBL3895324,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,944.0,nM,CHEMBL3887097,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,EC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C(=O)C(C)(C)[C@H]1O,6.025028005701931
CHEMBL64804,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,59.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,7.229147988357855
CHEMBL62570,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,16.5,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,7.782516055786093
CHEMBL3955128,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,205.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,6.688246138944246
CHEMBL3895047,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1630.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCc1ccc(C(=O)O)cc1,5.787812395596042
CHEMBL3923027,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1960.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCc1ccc(C(=O)O)cc1,5.707743928643524
CHEMBL3949856,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,763.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.117475462045119
CHEMBL3975743,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,148.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.8297382846050425
CHEMBL3937596,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,65.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCc1ccccc1)[C@@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,7.187086643357144
CHEMBL3900979,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1310.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCc1ccccc1)[C@H](O)CC[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,5.882728704344236
CHEMBL3916499,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,326.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.486782399932061
CHEMBL3902065,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1000.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](Cc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.0
CHEMBL3966743,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,743.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCc1ccccc1)[C@@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.129011186239424
CHEMBL3945327,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,157.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCCc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,6.804100347590767
CHEMBL3968443,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,1020.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCCCc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,5.991399828238082
CHEMBL3893847,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,79000.0,nM,CHEMBL3887484,B,"SEAP Activity Assay: 1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the plate in a 37° C. incubator with 5% CO2 and incubate overnight. 2. After 16-18 hours of incubation, aspirate the culture media from each well. 3. Add 200 ul of culture medium containing different concentration of test compounds to the assigned wells. For each test compound, at least 8 concentrations starting at highest 10 M and lowest 0.01 pM were tested. In addition each concentration had triplicates. A PGE2 curve (concentrations from lowest to highest, 0 pM, 0.384 pM, 1.92 pM, 9.6 pM, 48 pM, 240 pM, 1200 pM, and 6000 pM) was always run in parallel with test compounds. 4. After 6-8 hours of stimulation with test compounds and PGE2, 10 ul of culture media from each well was transferred to a corresponding well of a 96-well solid black plate. Cover the plate with the lid.",CHEMBL3886335,EC50,C[C@@H](CCCCCc1ccccc1)[C@@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,4.102372908709558
CHEMBL3965497,CHEMBL1881,Prostanoid EP2 receptor,EC50,=,96.0,nM,CHEMBL3888401,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10N HCl is added to achieve a pH of 7.4). The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 °C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2a (5 nM) were performed in a 100 μl volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell harvester. The filters were washed 3 times with ice-cold buffer and oven dried for one hour. [3H−] PGE2 (specific activity 180 Ci mmol) was used as the radioligand for EP receptors. [3H] 17-phenyl PGF2a was employed for FP receptor binding studies. Binding studies employing EP1, EP2, EP4 and FP receptors were performed in duplicate in at least three separate experiments. A 200 μl assay volume was used. Incubations were for 60 min at 25 °C. and were terminated by the addition of 4 ml of ice-cold 50 mM TRIS-HCl, followed by rapid filtration through Whatman GF/B filters and three additional 4 ml washes in a cell harvester (Brandel). Competition studies were performed using a final concentration of 5 nM [3H]-PGE2, or 5 nM [3H] 17-phenyl PGF2a and non-specific binding determined with 10^−5M of unlabeled PGE2, or 17-phenyl PGF2a, according to receptor subtype studied.",CHEMBL3886696,EC50,O=C(O)c1ccc(CCCN2[C@@H](/C=C/C(O)Cc3cccc(OC(F)(F)F)c3)CCS2(=O)=O)s1,7.017728766960431
